Health
Argonne’s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials – News-Medical.net
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two…
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter…
-
General15 hours agoThe wrong way to respond to antisemitism • Inside Story
-
Noosa News22 hours agoElderly pair killed in rural highway intersection crash with caravan
-
Business23 hours ago3 of the best ASX shares to buy with $5,000
-
Noosa News15 hours agoBrisbane community mourns 14-year-old Declan Phillips after deadly Wynnum crash